Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hwasun Pharma is a South Korean pharmaceutical company primarily focused on the manufacturing and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates within the Hwasun Vaccine Specialized Special Zone, a major biotech and vaccine cluster in South Korea, where it leverages local infrastructure for production. Its business model encompasses contract manufacturing (CMO) services for both domestic and international partners, specializing in high-quality chemical synthesis. Hwasun Pharma provides a range of essential medicines and generic drugs, contributing to the regional healthcare supply chain. The company is recognized for its adherence to Good Manufacturing Practice (GMP) standards in its production facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hwasun Pharma.